New Journal Website is available at: http://www.journalonweb.com/rcm

Published by: Neoscriber Demo Publisher

No-reflow Phenomenon After Primary Percutaneous Coronary Intervention: To Reflow or not to Reflow?

Turgay Celik 1 , * , Cengiz Ozturk 1 , Sevket Balta 1 and Atila Iyisoy 1
Authors Information
1 Gulhane Military Medical Academy, School of Medicine, Department of Cardiology, Etlik-Ankara, Turkey
Article information
  • Research in Cardiovascular Medicine: March 2017, 6 (2); e13361
  • Published Online: August 30, 2016
  • Article Type: Letter
  • Received: February 23, 2016
  • Accepted: March 29, 2016
  • DOI: 10.5812/cardiovascmed.37379

To Cite: Celik T, Ozturk C, Balta S, Iyisoy A. No-reflow Phenomenon After Primary Percutaneous Coronary Intervention: To Reflow or not to Reflow?, Res Cardiovasc Med. 2017 ;6(2):e13361. doi: 10.5812/cardiovascmed.37379.

Copyright: Copyright © 2017, Research in Cardiovascular Medicine. .
Footnote
References
  • 1. Abdi S, Rafizadeh O, Peighambari M, Basiri HA, Bakhshandeh H. Evaluation of the clinical and procedural predictive factors of no-reflow phenomenon following primary percutaneous coronary intervention. Res Cardiovascular Med. 2015; 4(2): 25414
  • 2. Magro M, Springeling T, van Geuns RJ, Zijlstra F. Myocardial 'no-reflow' prevention. Curr Vasc Pharmacol. 2013; 11(2): 263-77[PubMed]
  • 3. Wong DT, Puri R, Richardson JD, Worthley MI, Worthley SG. Myocardial 'no-reflow'--diagnosis, pathophysiology and treatment. Int J Cardiol. 2013; 167(5): 1798-806[DOI][PubMed]
  • 4. Balta S, Celik T, Mikhailidis DP, Ozturk C, Demirkol S, Aparci M, et al. The Relation Between Atherosclerosis and the Neutrophil-Lymphocyte Ratio. Clin Appl Thromb Hemost. 2016; 22(5): 405-11[DOI][PubMed]
  • 5. Celik T, Balta S, Demir M, Yildirim AO, Kaya MG, Ozturk C, et al. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Cardiol J. 2016; 23(1): 84-92[DOI][PubMed]
  • 6. Celik T, Kaya MG, Akpek M, Gunebakmaz O, Balta S, Sarli B, et al. Predictive value of admission platelet volume indices for in-hospital major adverse cardiovascular events in acute ST-segment elevation myocardial infarction. Angiology. 2015; 66(2): 155-62[DOI][PubMed]
  • 7. Celik T, Balta S, Ozturk C, Kaya MG, Aparci M, Yildirim OA, et al. Predictors of No-Reflow Phenomenon in Young Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Angiology. 2016; 67(7): 683-9[DOI][PubMed]
  • 8. Celik T, Kaya MG, Akpek M, Yarlioglues M, Sarli B, Topsakal R, et al. Does Serum Bilirubin level on admission predict TIMI flow grade and in-hospital MACE in patients with STEMI undergoing primary PCI. Angiology. 2014; 65(3): 198-204[DOI][PubMed]
  • 9. Akpek M, Kaya MG, Lam YY, Sahin O, Elcik D, Celik T, et al. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol. 2012; 110(5): 621-7[DOI][PubMed]
  • 10. Yuksel UC, Celik T, Celik M, Bugan B, Iyisoy A, Yaman H. High admission levels of gamma-glutamyltransferase predict poor myocardial perfusion after primary percutaneous intervention. Clinics (Sao Paulo). 2011; 66(10): 1729-34[PubMed]
  • 11. Celik T, Iyisoy A, Yuksel CU, Kilic S, Yilmaz MI, Akgul EO, et al. Impact of admission glomerular filtration rate on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction. Coron Artery Dis. 2008; 19(8): 543-9[DOI][PubMed]
  • 12. Celik T, Turhan H, Kursaklioglu H, Iyisoy A, Yuksel UC, Ozmen N, et al. Impact of metabolic syndrome on myocardial perfusion grade after primary percutaneous coronary intervention in patients with acute ST elevation myocardial infarction. Coron Artery Dis. 2006; 17(4): 339-43[PubMed]
  • 13. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002; 105(9): 1135-43[PubMed]
  • 14. Lagrand WK, Niessen HW, Wolbink GJ, Jaspars LH, Visser CA, Verheugt FW, et al. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation. 1997; 95(1): 97-103[PubMed]
  • 15. Celik T, Iyisoy A, Yuksel UC, Jata B, Ozkan M. The impact of admission C-reactive protein levels on the development of no-reflow phenomenon after primary PCI in patients with acute myocardial infarction: the role of inflammation. Int J Cardiol. 2009; 136(1): 86-8[DOI][PubMed]
  • 16. Celik T, Iyisoy A, Kursaklioglu H, Turhan H, Kilic S, Kose S, et al. The impact of admission C-reactive protein levels on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction. Coron Artery Dis. 2005; 16(5): 293-9[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader